Free Trial

Jamieson Wellness (TSE:JWEL) Trading Up 0.7% - Should You Buy?

Jamieson Wellness logo with Consumer Defensive background

Key Points

  • Jamieson Wellness Inc. (TSE: JWEL) saw a mid-day trading increase of 0.7%, with a last trading price of C$35.13, although trading volume was down 58% from the average.
  • Analysts have recently rated Jamieson Wellness as a Buy, with price targets raised by BMO Capital, National Bank, and TD Securities, suggesting an average target of C$42.40.
  • Insider selling was noted, with Christopher Snowden and Paul Michael Galbraith significantly reducing their holdings, indicating potential concerns from company insiders.
  • Interested in Jamieson Wellness? Here are five stocks we like better.

Jamieson Wellness Inc. (TSE:JWEL - Get Free Report)'s stock price was up 0.7% during mid-day trading on Wednesday . The company traded as high as C$35.29 and last traded at C$35.13. Approximately 29,227 shares changed hands during trading, a decline of 58% from the average daily volume of 69,081 shares. The stock had previously closed at C$34.90.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on JWEL shares. BMO Capital Markets boosted their price objective on Jamieson Wellness from C$41.00 to C$42.00 and gave the stock an "outperform" rating in a report on Friday, August 8th. National Bankshares lifted their price target on shares of Jamieson Wellness from C$40.00 to C$40.60 and gave the company an "outperform" rating in a research report on Friday, August 8th. Finally, TD Securities lifted their price target on shares of Jamieson Wellness from C$42.00 to C$45.00 and gave the company a "buy" rating in a research report on Friday, August 8th. Four research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average price target of C$42.40.

Get Our Latest Stock Report on Jamieson Wellness

Jamieson Wellness Trading Up 0.7%

The firm has a market capitalization of C$1.46 billion, a price-to-earnings ratio of 26.41 and a beta of 1.20. The company has a debt-to-equity ratio of 75.70, a current ratio of 2.76 and a quick ratio of 1.08. The firm's 50-day simple moving average is C$36.45 and its 200 day simple moving average is C$34.69.

Insider Buying and Selling at Jamieson Wellness

In other news, insider Christopher Snowden sold 106,852 shares of the company's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of C$36.03, for a total transaction of C$3,850,198.12. Following the completion of the transaction, the insider directly owned 172,021 shares in the company, valued at approximately C$6,198,432.69. This represents a 38.32% decrease in their ownership of the stock. Also, insider Paul Michael Galbraith sold 7,905 shares of the company's stock in a transaction on Tuesday, August 26th. The stock was sold at an average price of C$36.50, for a total transaction of C$288,510.37. Following the transaction, the insider owned 5,366 shares of the company's stock, valued at C$195,843.98. This trade represents a 59.57% decrease in their ownership of the stock. 0.26% of the stock is currently owned by corporate insiders.

Jamieson Wellness Company Profile

(Get Free Report)

Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Jamieson Wellness Right Now?

Before you consider Jamieson Wellness, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jamieson Wellness wasn't on the list.

While Jamieson Wellness currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.